For participants ages 18-65 to evaluate the efficacy, safety and tolerability of a single dose of study medication in the acute treatment of migraines. There are a total of 3 study visits and you will be compensated for your time.: For participants ages 18-65 to evaluate the efficacy, safety and tolerability of a single dose of study medication in the acute treatment of migraines. There are a total of 3 study visits and you will be compensated for your time.

PLAINS